A study by Roche arrived in a conclusion that a combination treatment of Tecentriq (atezolizumab) and Avastin (bevacizumab) decreases the risk of worsening of advanced kidney cancer patients’ disease.
Tecentriq is an antibody engineered to bind to PD-L1, and is...
With the results and findings posted in Applied Nano Materials, scientists are making nanoparticles from tealeaves. While testing, the nanoparticles destroyed about 80 percent of the lung cancer cells.
Nanoparticles have been in study for a couple years now, but scientists...
